Validation of the French translation-adaptation of the impact of cancer questionnaire version 2 (IOCv2) in a breast cancer survivor population

被引:8
作者
Blanchin, Myriam [1 ]
Dauchy, Sarah [2 ]
Cano, Alejandra [2 ]
Bredart, Anne [3 ,4 ]
Aaronson, Neil K. [5 ]
Hardouin, Jean-Benoit [1 ,6 ]
机构
[1] Univ Nantes, Biostat Pharmacoepidemiol & Subject Measures Hlth, EA4275, Nantes, France
[2] Gustave Roussy, Psychooncol Unit, Dept Support Care, Villejuif, France
[3] Inst Curie, Psychooncol Unit, Dept Support Care DISSPO, Paris, France
[4] Univ Paris 05, Psychopathol & Hlth Proc Lab LPPS, EA 4057, Paris, France
[5] Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands
[6] Univ Hosp Nantes, Unit Methodol & Biostat, Nantes, France
来源
HEALTH AND QUALITY OF LIFE OUTCOMES | 2015年 / 13卷
关键词
Cancer survivor; Survivorship; Breast cancer; Questionnaire; Psychometric properties; Psychosocial; QUALITY-OF-LIFE; NON-HODGKIN-LYMPHOMA; POSTTRAUMATIC GROWTH; HEALTH SURVEY; INSTRUMENT; INVENTORY;
D O I
10.1186/s12955-015-0301-x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The Impact of Cancer version 2 (IOCv2) was designed to assess the physical and psychosocial health experience of cancer survivors through its positive and negative impacts. Although the IOCv2 is available in English and Dutch, it has not yet been validated for use in French-speaking populations. The current study was undertaken to provide a comprehensive assessment of the reliability and validity of the French language version of the IOCv2 in a sample of breast cancer survivors. Methods: An adapted French version of the IOCv2 as well as demographic and medical information were completed by 243 women to validate the factor structure divergent/divergent validities and reliability. Concurrent validity was assessed by correlating the IOCv2 scales with measures from the SF-12, PostTraumatic Growth Inventory and Fear of Cancer Recurrence Inventory. Results: The French version of the IOCv2 supports the structure of the original version, with four positive impact dimensions and four negative impact dimensions. This result was suggested by the good fit of the confirmatory factor analysis and the adequate reliability revealed by Cronbach's alpha coefficients and other psychometric indices. The concurrent validity analysis revealed patterns of association between IOCv2 scale scores and other measures. Unlike the original version, a structure with a Positive Impact domain consisting in the IOCv2 positive dimensions and a Negative Impact domain consisting in the negative ones has not been clearly evidenced in this study. The limited practical use of the conditional dimensions Employment Concerns and Relationship Concerns, whether the patient is partnered or not, did not make possible to provide evidence of validity and reliability of these dimensions as the subsets of sample to work with were not large enough. The scores of these conditional dimensions have to be used with full knowledge of the facts of this limitation of the study. Conclusions: Integrating IOCv2 into studies will contribute to evaluate the psychosocial health experience of the growing population of cancer survivors, enabling better understanding of the multi-dimensional impact of cancer.
引用
收藏
页数:12
相关论文
共 28 条
  • [1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
    AARONSON, NK
    AHMEDZAI, S
    BERGMAN, B
    BULLINGER, M
    CULL, A
    DUEZ, NJ
    FILIBERTI, A
    FLECHTNER, H
    FLEISHMAN, SB
    DEHAES, JCJM
    KAASA, S
    KLEE, M
    OSOBA, D
    RAZAVI, D
    ROFE, PB
    SCHRAUB, S
    SNEEUW, K
    SULLIVAN, M
    TAKEDA, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 365 - 376
  • [2] [Anonymous], 2002, Introduction to Nonparametric Item Response Theory, DOI DOI 10.4135/9781412984676
  • [3] Assessing Quality of Life in Adult Cancer Survivors (QLACS)
    Avis, NE
    Smith, KW
    McGraw, S
    Smith, RG
    Petronis, VM
    Carver, CS
    [J]. QUALITY OF LIFE RESEARCH, 2005, 14 (04) : 1007 - 1023
  • [4] Cancer and beyond: The question of survivorship
    Breaden, K
    [J]. JOURNAL OF ADVANCED NURSING, 1997, 26 (05) : 978 - 984
  • [5] THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE
    CELLA, DF
    TULSKY, DS
    GRAY, G
    SARAFIAN, B
    LINN, E
    BONOMI, A
    SILBERMAN, M
    YELLEN, SB
    WINICOUR, P
    BRANNON, J
    ECKBERG, K
    LLOYD, S
    PURL, S
    BLENDOWSKI, C
    GOODMAN, M
    BARNICLE, M
    STEWART, I
    MCHALE, M
    BONOMI, P
    KAPLAN, E
    TAYLOR, S
    THOMAS, CR
    HARRIS, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) : 570 - 579
  • [6] Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors
    Crespi, Catherine M.
    Smith, Sophia K.
    Petersen, Laura
    Zimmerman, Sheryl
    Ganz, Patricia A.
    [J]. JOURNAL OF CANCER SURVIVORSHIP, 2010, 4 (01) : 45 - 58
  • [7] Refinement and Psychometric Evaluation of the Impact of Cancer Scale
    Crespi, Catherine M.
    Ganz, Patricia A.
    Petersen, Laura
    Castillo, Adrienne
    Caan, Bette
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (21): : 1530 - 1541
  • [8] Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297
  • [9] The Challenges of Colorectal Cancer Survivorship
    Denlinger, Crystal S.
    Barsevick, Andrea M.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (08): : 883 - 893
  • [10] Dewolf L., 2009, EORTC Quality of life Group Translation Procedure